Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
111M
-
Number of holders
-
27
-
Total 13F shares, excl. options
-
10.3M
-
Shares change
-
+634K
-
Total reported value, excl. options
-
$29.1M
-
Value change
-
+$1.67M
-
Number of buys
-
10
-
Number of sells
-
-4
-
Price
-
$2.81
Significant Holders of InspireMD, Inc. - Common Shares (NSPR) as of Q4 2023
30 filings reported holding NSPR - InspireMD, Inc. - Common Shares as of Q4 2023.
InspireMD, Inc. - Common Shares (NSPR) has 27 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 10.3M shares
of 111M outstanding shares and own 9.32% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (2.13M shares), Nantahala Capital Management, LLC (2.07M shares), MARSHALL WACE, LLP (1.86M shares), Soleus Capital Management, L.P. (1.38M shares), Rosalind Advisors, Inc. (925K shares), Velan Capital Investment Management LP (904K shares), PURA VIDA INVESTMENTS, LLC (451K shares), MILLENNIUM MANAGEMENT LLC (348K shares), MORGAN STANLEY (63.5K shares), and Mesirow Financial Investment Management, Inc. (30K shares).
This table shows the top 27 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.